Project Details
| Status | Active |
|---|---|
| Effective start/end date | 06/25/25 → 06/30/27 |
Funding
- Noema Pharma: $49,186.60
A Double-Blind, Placebo-Controlled, Phase IIb, Multi-center, Twelve-week Prospective Study to Evaluate the Efficacy and Safety of Gemlapodect in Adult and Adolescent Patients with Tourette Syndrome
- Maurer, Carine (PI)
- Schwartz, Guy (CoPI)
Project: Research